Targeting colorectal cancer with anti-epidermal growth factor receptor antibodies: focus on panitumumab

Panitumumab is a fully humanized monoclonal antibody with a high degree of affinity for the extracellular domain of the epidermal growth factor receptor. Phase II clinical evaluation of this drug, when administered as a single agent, in patients with metastatic colorectal cancer refractory to chemot...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoda, Daanish, Simon, George R, Garrett, Christopher R
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2643103/
https://www.ncbi.nlm.nih.gov/pubmed/19337429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2643103/
https://www.ncbi.nlm.nih.gov/pubmed/19337429

Ejemplares similares